Listen to Addiction Psychiatrist Elizabeth “Libby” Stuyt’s discussion on High Truths on Drugs and Addiction, Episode #58

High potency THC is associated with psychosis and schizophrenia. Why are we not following the science? Join us with Dr. Elizabeth Stuyt as we discuss the concerning increase of THC potency in cannabis and how it can affect our brain. Increased paranoia, psychosis, and schizophrenia are examples of conditions we are seeing more and more of in our emergency rooms. When the toxicology report comes back, the only drug in their system is the high potency THC cannabis.

Listen Now

About Elizabeth ‘Libby’ Stuyt, MD
Dr. Stuyt is a board-certified Addiction Psychiatrist and has worked in the addiction/behavioral health field since 1990. She was the Medical Director for the Circle Program, a 90-day inpatient treatment program, funded by the state of Colorado, for persons with co-occurring mental illness and substance abuse who have failed other levels of treatment from 1999 to 2020. She retired from this position in May 2020 in order to spend more time attempting to educate as many people as possible on the un-intended consequences she has seen from the commercialization of marijuana in Colorado, focusing primarily on the deleterious effects of high potency THC on the developing brain and mental health.

Listen to Episode #58 Now

 

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents  Cannabis and Mental Health

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Placebo Effect a Major Driver of Pain Reduction in Cannabis Trials

A strong placebo response may be largely responsible for the significant pain reduction observed in clinical trials of cannabis-based therapies, results of a new meta-analysis suggest. Investigators found that while the effect size of cannabinoids on pain intensity was significant, the placebo effect was about the same. “The data from the present meta-analysis, including 1459

Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005–2019

Since 2005, diagnoses of cannabis use disorder have increased substantially among VHA patients, as they have in the general population and other patient populations. Possible explanations warranting investigation include decreasing perception of risk, changing laws, increasing cannabis potency, stressors related to growing socioeconomic inequality, and use of cannabis to self-treat pain. Clinicians and the public

Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado

The primary objective of this study was to evaluate the association between presence of recreational cannabis dispensaries and prevalence of cannabis-involved pregnancy hospitalizations in Colorado. This was a retrospective cohort study of pregnancy-related hospitalizations co-coded with cannabis diagnosis codes in the Colorado Hospital Association from January 1, 2011, through December 31, 2018 (recreational cannabis began

Scroll to Top